CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 790 enrolled
Drug / intervention
6-month PrEP + blood-based HIV self-test +1 morecombination
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03593629
NCT03593629N/ACompleted
CompareCT.gov

HIV Self-Testing to Improve the Efficiency of PrEP Delivery

University of Washington·interventional·Posted Jul 20, 2018·Updated Jun 4, 2024

In Brief

A clinical study evaluating 6-month PrEP + blood-based HIV self-test and 6-month PrEP + oral fluid HIV self-test for HIV-1-infection. Completed, enrolled 790 participants across 1 site.

Detailed Summary

In a three-arm, randomized trial, the investigators will test the use of HIV-1 self-testing to decrease the frequency and burden of clinic visits for PrEP while resulting in equivalent PrEP adherence and HIV testing.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV-1-infection
CountriesKenya
CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJul 20, 2018
Enrollment StartMay 28, 2018
Primary CompletionDec 10, 2020
Study CompletionMay 25, 2021
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 8.0 years ago

Interventions

6-month PrEP + blood-based HIV self-testcombination

Participants receive 6-month PrEP supply plus two blood-based HIV self-tests (Atomo Diagnostics Blood-Based HIV-1 Self-Testing Kit) for quarterly HIV testing.

6-month PrEP + oral fluid HIV self-testcombination

Participants receive 6-month PrEP supply plus two oral fluid HIV self-tests (OraQuick Oral Fluid-based HIV-1 Self-Testing Kit) for quarterly HIV testing.